Are Angiotensin II Receptor Blockers Really Safe From Aminotransferase Elevation or Drug-Induced Liver Injury?
Jang BK.
J Korean Med Sci. 2022 Aug 22;37(33):e261. doi: 10.3346/jkms.2022.37.e261.
Spironolactone-potion or poison?
[No authors listed]
Drug Ther Bull. 2017 Feb;55(2):13. doi: 10.1136/dtb.2017.2.0452. Epub 2017 Feb 2.
The Pharmacogenomic and Metabolomic Predictors of ACE Inhibitor and Angiotensin II Receptor Blocker Effectiveness and Safety.
Flaten HK, Monte AA.
Cardiovasc Drugs Ther. 2017 Aug;31(4):471-482. doi: 10.1007/s10557-017-6733-2.
Evaluation of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy in immunotherapy-associated systemic reactions.
Carlson GS, Wong PH, White KM, Quinn JM.
J Allergy Clin Immunol Pract. 2017 Sep-Oct;5(5):1430-1432. doi: 10.1016/j.jaip.2017.05.009. Epub 2017 Jul 8.
Les enjeux de la surcharge hydro-sodée.
Vrtovsnik F, Fartoux L.
Nephrol Ther. 2016 Dec;12(7S):S10-S11. doi: 10.1016/S1769-7255(17)30020-2.
Hypertension in Bangladesh: a review.
Islam AK, Majumder AA.
Indian Heart J. 2012 May-Jun;64(3):319-23. doi: 10.1016/S0019-4832(12)60096-0.
The potential therapeutic use of renin-angiotensin system inhibitors in the treatment of inflammatory diseases.
Ranjbar R, Shafiee M, Hesari A, Ferns GA, Ghasemi F, Avan A.
J Cell Physiol. 2019 Mar;234(3):2277-2295. doi: 10.1002/jcp.27205. Epub 2018 Sep 7.
Losartan-induced hepatotoxicity.
Bosch X.
JAMA. 1997 Nov 19;278(19):1572.
Unintentional paediatric ingestions of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists.
Balit CR, Gilmore SP, Isbister GK.
J Paediatr Child Health. 2007 Oct;43(10):686-8. doi: 10.1111/j.1440-1754.2007.01188.x.
Angiotensin axis antagonists increase the incidence of haemodynamic instability in dihydropyridine calcium channel blocker poisoning.
Huang J, Buckley NA, Isoardi KZ, Chiew AL, Isbister GK, Cairns R, Brown JA, Chan BS.
Clin Toxicol (Phila). 2021 Jun;59(6):464-471. doi: 10.1080/15563650.2020.1826504. Epub 2020 Oct 6.
